United Guardian (UG) Change in Accured Expenses (2010 - 2026)
United Guardian's (UG) quarterly Change in Accured Expenses came in at -$97054.0 in Q2 2026, up 57.78% year-over-year from -$61512.9 in Q2 2025, and down 164.09% quarter-over-quarter from $151439.0 in Q1 2026.
Analysis
United Guardian (UG) Change in Accured Expenses (2010 - 2026) Analysis & Trends
United Guardian has disclosed Change in Accured Expenses across 17 years of filings, most recently posting -$97054.0 for Q2 2026.
- In Q2 2026, Change in Accured Expenses rose 57.78% year-over-year to -$97054.0; the TTM figure through Jun 2026 stood at -$78536.0 (down 38.06% YoY), while the FY2025 annual figure was -$302985.0, down 388.86% from the prior year.
- Change in Accured Expenses came in at -$97054.0 for Q2 2026 at United Guardian, down from $151439.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $151439.0 in Q1 2026 to a low of -$229867.0 in Q2 2025.
- Average Change in Accured Expenses over 5 years is -$22669.8, with a median of -$3602.0 recorded in 2022.
- The largest YoY upside for Change in Accured Expenses was 13958.92% in 2023 against a maximum downside of 1214.93% in 2023.
- Over 5 years, Change in Accured Expenses stood at -$224581.0 in 2022, then surged by 134.23% to $76878.0 in 2023, then surged by 65.76% to $127432.0 in 2024, then tumbled by 238.58% to -$176592.0 in 2025, then soared by 45.04% to -$97054.0 in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$97054.0 in Q2 2026, $151439.0 in Q1 2026, and -$176592.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.97 Bn | 622.21 Bn | 17.26 Bn | 2.32 Bn |
| 2 | AbbVie | 441.24 Bn | 434.67 Bn | 12.70 Bn | 1.20 Bn |
| 3 | Merck | 364.65 Bn | 357.51 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.30 Bn | 258.61 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - | 55.78 Mn |
| 8 | Incyte | 25.27 Bn | 20.73 Bn | 1.57 Bn | -204.33 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn | -4.00 Mn |
| 10 | United Guardian | 32.67 Mn | 23.07 Mn | 1.55 Mn | -97,054.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -97,054.00 |
| Mar 31, 2026 | 151,439.00 |
| Dec 31, 2025 | -176,592.00 |
| Sep 30, 2025 | 43,671.00 |
| Jun 30, 2025 | -229,867.00 |
| Mar 31, 2025 | 59,803.00 |
| Dec 31, 2024 | 127,432.00 |
| Sep 30, 2024 | -14,252.00 |
| Jun 30, 2024 | -67,566.00 |
| Mar 31, 2024 | 59,275.00 |
| Dec 31, 2023 | 76,878.00 |
| Sep 30, 2023 | 109,519.00 |
| Jun 30, 2023 | -137,426.00 |
| Mar 31, 2023 | -7,983.00 |
| Dec 31, 2022 | -224,581.00 |
| Sep 30, 2022 | 779.00 |
| Jun 30, 2022 | 12,326.00 |
| Mar 31, 2022 | -93,858.00 |
| Dec 31, 2021 | 84,630.00 |
| Sep 30, 2021 | 138,035.00 |